Capricor Therapeutics (CAPR) EBT: 2011-2025
Historic EBT for Capricor Therapeutics (CAPR) over the last 13 years, with Sep 2025 value amounting to -$24.6 million.
- Capricor Therapeutics' EBT fell 95.68% to -$24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.4 million, marking a year-over-year decrease of 100.10%. This contributed to the annual value of -$40.4 million for FY2024, which is 80.60% down from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' EBT is -$24.6 million, which was down 1.31% from -$24.3 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' EBT ranged from a high of -$829,093 in Q4 2023 and a low of -$24.6 million during Q3 2025.
- Moreover, its 3-year median value for EBT was -$8.8 million (2023), whereas its average is -$11.2 million.
- In the last 5 years, Capricor Therapeutics' EBT spiked by 89.21% in 2023 and then slumped by 745.66% in 2024.
- Capricor Therapeutics' EBT (Quarterly) stood at -$6.4 million in 2021, then fell by 20.79% to -$7.7 million in 2022, then skyrocketed by 89.21% to -$829,093 in 2023, then slumped by 745.66% to -$7.0 million in 2024, then slumped by 95.68% to -$24.6 million in 2025.
- Its EBT was -$24.6 million in Q3 2025, compared to -$24.3 million in Q2 2025 and -$7.0 million in Q4 2024.